BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34855235)

  • 21. Tenosynovial giant cell tumor of the upper cervical spine arising from the posterior atlanto-occipital membrane: a case report.
    Kim YJ; Hong JH; Park JH; Cho SJ
    Skeletal Radiol; 2021 Feb; 50(2):451-455. PubMed ID: 32767059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets.
    van der Heijden L; Spierenburg G; Kendal JK; Bernthal NM; van de Sande MAJ
    J Surg Oncol; 2023 Sep; 128(3):478-488. PubMed ID: 37537982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors.
    Thangaiah JJ; Koepplin JW; Folpe AL
    Hum Pathol; 2021 Sep; 115():1-9. PubMed ID: 34058245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
    Kitagawa Y; Takai S
    J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor.
    Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2021 Jan; 34(1):254-259. PubMed ID: 32886306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors.
    Baldi GG; Gronchi A; Stacchiotti S
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):571-576. PubMed ID: 32478598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor.
    Monestime S; Lazaridis D
    Drugs R D; 2020 Sep; 20(3):189-195. PubMed ID: 32617868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
    Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
    Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
    Tsuboi H; Udagawa N; Hashimoto J; Yoshikawa H; Takahashi N; Ochi T
    Arthritis Rheum; 2005 Dec; 52(12):3819-28. PubMed ID: 16320327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chondroid tenosynovial giant cell tumor: a clinicopathological and immunohistochemical analysis of 5 new cases.
    Hoch BL; Garcia RA; Smalberger GJ
    Int J Surg Pathol; 2011 Apr; 19(2):180-7. PubMed ID: 21087985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics.
    Steenvoorden MM; Tolboom TC; van der Pluijm G; Löwik C; Visser CP; DeGroot J; Gittenberger-DeGroot AC; DeRuiter MC; Wisse BJ; Huizinga TW; Toes RE
    Arthritis Res Ther; 2006; 8(6):R165. PubMed ID: 17076892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of JAK Inhibition on the Induction of Proinflammatory HLA-DR+CD90+ Rheumatoid Arthritis Synovial Fibroblasts by Interferon-γ.
    Zhao S; Grieshaber-Bouyer R; Rao DA; Kolb P; Chen H; Andreeva I; Tretter T; Lorenz HM; Watzl C; Wabnitz G; Tykocinski LO; Merkt W
    Arthritis Rheumatol; 2022 Mar; 74(3):441-452. PubMed ID: 34435471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.
    Ho J; Peters T; Dickson BC; Swanson D; Fernandez A; Frova-Seguin A; Valentin MA; Schramm U; Sultan M; Nielsen TO; Demicco EG
    Genes Chromosomes Cancer; 2020 Feb; 59(2):96-105. PubMed ID: 31469468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
    Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
    BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel comparison of fibroblast-like synoviocytes from the surgically removed hyperplastic synovial tissues of rheumatoid arthritis and osteoarthritis patients.
    Huang W; Zhang L; Cheng C; Shan W; Ma R; Yin Z; Zhu C
    BMC Musculoskelet Disord; 2019 Dec; 20(1):591. PubMed ID: 31812161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenosynovial giant cell tumor: case report and molecular investigation.
    Guimarães LM; Bastos VC; Souza MRF; de Castro WH; Gomes CC; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jul; 138(1):e13-e17. PubMed ID: 38760286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.